# clinical trials
Latest news and articles about clinical trials
Total: 2 articles found
Pfizer’s Monthly GLP‑1 Shows Promising Weight‑Loss Signal — A New Challenger in a Crowded Market
Pfizer’s long‑acting GLP‑1 candidate PF‑08653944 produced a 12.3% placebo‑adjusted mean weight loss at 28 weeks and sustained reductions after switching to monthly dosing, with mainly mild‑to‑moderate gastrointestinal side effects. The company has launched an ambitious phase 3 programme of ten trials and plans to advance full development in 2026, positioning itself to challenge incumbent GLP‑1 therapies if larger trials confirm efficacy and safety.
When Compute Meets Patients: How AI Is Rewiring Drug Discovery—and China and the US Are Betting Different Chips
AI is transforming drug discovery from an expensive exercise in trial-and-error into a data- and compute-driven engineering problem. The result is a pragmatic partnership between American algorithmic and compute strength and China’s unrivalled clinical scale, producing record licensing deals even as regulatory and scientific bottlenecks persist.